| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 124.506 | 78 |
| GSM780708 | Untreated after 4 days (C2_1) | 86.4253 | 73 |
| GSM780709 | Untreated after 4 days (C3_1) | 64.6774 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 117.348 | 77 |
| GSM780720 | Untreated after 4 days (C2_2) | 100.846 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 80.2194 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 107.457 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 107.892 | 76 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 109.453 | 76 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 89.4898 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 106.622 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 119.465 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 99.2746 | 75 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 92.6481 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 95.8363 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 93.0741 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 95.6486 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 97.1108 | 75 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 100.752 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 90.4356 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 103.385 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 106.797 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 112.894 | 77 |